Institutional Clinical and Translational Science Award
The summary for the Institutional Clinical and Translational Science Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Institutional Clinical and Translational Science Award: - Purpose: Growing barriers between clinical and basic research, along with the ever increasing complexities involved in conducting clinical research, are making it more difficult to translate new knowledge to the clinic -- and back again to the bench. These challenges are limiting professional interest in the field and hampering the clinical research enterprise at a time when it should be expanding. - The purpose of this initiative is to assist institutions to forge a uniquely transformative, novel, and integrative academic home for Clinical and Translational Science that has the consolidated resources to: 1) captivate, advance, and nurture a cadre of well-trained multi- and inter-disciplinary investigators and research teams; 2) create an incubator for innovative research tools and information technologies; and 3) synergize multi-disciplinary and inter-disciplinary clinical and translational research and researchers to catalyze the application of new knowledge and techniques to clinical practice at the front lines of patient care.
|Federal Grant Title:||Institutional Clinical and Translational Science Award|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Education Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-RM-06-002|
|Type of Funding:||Cooperative Agreement|
|CFDA Descriptions:||Research Infrastructure|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Mar 27, 2006|
|Posted Date:||Oct 12, 2005|
|Creation Date:||Oct 12, 2005|
|Archive Date:||Apr 26, 2006|
|Total Program Funding:||$30,000,000|
|Maximum Federal Grant Award:||$6,000,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Domestic institutions including universities, academic health centers, or other research organizations conducting translational and clinical research are eligible, with the following requirements. Because the Institutional CTSA program is focused on the development of a rigorous and robust academic discipline of clinical and translational science, the applicant institution(s) must include a graduate school accredited to award higher degrees in clinical research. Potential applicants and their affiliates without higher-degree awarding authority should consider applying for a CTSA Planning Grant (RFA-RM-06-001). Examples of acceptable higher degrees include M.S. and Ph. D. in topics such as Clinical Research, Public Health, Pharmacology, Nursing and Epidemiology. Partnerships among schools of medicine, dentistry, nursing, pharmacy, osteopathy, public health, engineering and other clinically-related institutions are strongly encouraged, as is the inclusion of other relevant cli! nical research entities and organizations. The CTSA institution(s) is expected to form an integrated institutional home that includes faculty committed to developing the discipline of clinical and translational science that will transcend multiple departments, schools, clinical and research institutes and hospitals. Therefore, an institution may submit, or be part of, only a single application in response to this RFA. Multiple applications from different divisions, faculties, centers, schools, etc. of the same university or medical school will be returned without further consideration by the NIH. Institutions whose faculties hold positions at two or more universities, medical, or osteopathic schools, etc. can be part of only a single application at a time. Foreign institutions and foreign components of applications are not allowed. Applications from ineligible institutions will not be reviewed. The application must include clear detailed evidence of significant institutiona! l commitment.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
- Similar Government Grants
- • Limited Competition: Competitive Revision for Technology Development within Biomedical Tec...
- • Centers of Biomedical Research Excellence (COBRE) (P20)
- • Instrument Development for Biomedical Applications (R21)
- • Limited Competition: Institutional Development Award (IDeA) Program Infrastructure for Cli...
- • High-End Instrumentation Grant Program (S10)
- • NCRR Science Education Partnership Award (SEPA) [R25]
- • Planning Grants for Institutional Clinical and Translational Science Awards
- • Ncrr Shared Instrumentation Grant (Sig) Program
- More Grants from the National Institutes of Health
- • Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses f...
- • Environmental influences on Placental Origins of Development (ePOD) (R01)
- • Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)